Rates of Problem Marijuana Use Are Rising Among Seniors

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 18, 2024.

By Ernie Mundell HealthDay Reporter

TUESDAY, June 18, 2024 -- As marijuana use becomes legal and more accepted across America, more seniors are developing unhealthy relationships with the drug, a new report suggests.

A look at data on almost 56 million Medicare beneficiaries finds "rates of health care encounters with cannabis-related disorders increased from 2017 through 2022," according to a study led by Dr. Silvia Perez-Vilar, of the U.S. Food and Drug Administration.

The FDA team's analysis included all Medicare recipients except nursing home residents. It focused on Medicare claims mentioning any medical incident linked to cannabis use.

The numbers showed a steady increase in cannabis-linked medical care among seniors over the five years of the study.

By 2022, "rates were greatest in states or territories with both adult and medical use legalization," the team found, with about 45 such cases recorded for every 10,000 Medicare claims.

Rates of cannabis-linked claims were slightly lower in states where medical marijuana was legal, but recreational use was not (41.5 cases per 10,000).

In states where marijuana use was still illegal for either recreational or medical reasons, the rate of weed-linked claims among seniors fell to 27.7 cases per 10,000, Perez-Vilar's team said.

Experts have voiced concerns over the rise in addictions and mental health crises linked to highly potent cannabis in the past few years, mainly among the young. For example, one recent study found that teens who use cannabis face 11 times the odds for a psychotic episode compared to teens who abstain from the drug.

The new study suggests that these dangers may extend to older adults.

"Overall, data suggest that increasing rates of health care encounters documenting cannabis-related disorders among older adults might be associated with the type of cannabis legalization," the FDA team said.

The findings were published June 18 in the journal JAMA Network Open.

Sources

  • JAMA Network Open, June 18, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-06-19 01:15

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords